Julie Gralow, Chief Medical Officer of the American Society of Clinical Oncology, shared post on LinkedIn:
“Federally funded cancer research fuels lifesaving discoveries that bring hope to people with cancer and their loved ones. For millions of Americans, research has changed what a cancer diagnosis means, allowing patients to carry far more hope: death rates have continuously declined since the 1990s, and 5-year survival rates for all cancers have reached an all-time high.
Last week, the President’s FY27 budget request was released, proposing a 12% cut in funding for NIH and a modest increase in funding for NCI.
At a time when federally funded research is delivering such unprecedented progress in cancer prevention, detection, and treatment, sustained funding is critically important.
Earlier this year, Congress recognized this and demonstrated bipartisan support for cancer research by rejecting proposed cuts. Today, I’m encouraging members of ASCO and the broader cancer community to contact their members of Congress, urging them to once again ensure sustained, robust investment in the NIH and NCI in the FY27 budget and save lives.
Take action and help ensure progress against cancer continues for patients for generations to come.”
Other articles featuring Julie Gralow on OncoDaily.